Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
41.54 USD
-1.89%
Market Closed
Updated:
May 23, 2024
Bristol-Myers Squibb Co
Short-Term Investments
|
Bristol-Myers Squibb Co
Short-Term Investments Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Short-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Short-Term Investments
$340m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-16%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Short-Term Investments
$19B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
18%
|
CAGR 10-Years
7%
|
|
|
Pfizer Inc
NYSE:PFE
|
Short-Term Investments
$11.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Short-Term Investments
$40m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-38%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Short-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Short-Term Investments
$126.1m
|
CAGR 3-Years
37%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-21%
|
See Also
What is Bristol-Myers Squibb Co's Short-Term Investments?
Short-Term Investments
340m
USD
340m
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Short-Term Investments amounts to 340m USD.
What is Bristol-Myers Squibb Co's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
-16%
-16%
Over the last year, the Short-Term Investments growth was 24%. The average annual Short-Term Investments growth rates for Bristol-Myers Squibb Co have been -44% over the past three years , -25% over the past five years , and -16% over the past ten years .
You don't have any saved screeners yet
